BioPharma Pharma Research
Advances World-Class Clinical Research Capabilities with Leading Regulatory-Grade Registries Platform Expected to Be Accretive to Adjusted Earnings Per Sh...
August 15, 2023 | News
Kelun-Biotech recently held an Independent Data Monitoring Committee (IDMC) meeting to review the interim analysis data of the Phase III clinical trial of ...
August 15, 2023 | News
The study is a prospective, self-controlled, multicenter Phase Ⅲ trial aimed at investigating the additional detection rate and safety of Hexvix®&nbs...
August 14, 2023 | News
Aichi Cancer Center and NEC developed a method for efficiently identifying lung cancer antigens (oncology marks) and antigen-specific T cells by comb...
August 10, 2023 | News
Lonza adds new Nebula® Absorbance Reader to its portfolio of Lonza-developed and optimized microplate readers for streamlined endotoxin and pyrogen t...
August 09, 2023 | News
Agilent Technologies Inc. (NYSE: A) announced the opening of a new full-scale Integrated Biology Center located at Monash University in Ma...
August 08, 2023 | News
The agreement further builds upon the strategic collaboration the companies announced in April 2023. Under the terms of the agreements, DualityBio will re...
August 08, 2023 | News
In the initial phase of the AF360 campaign, Pfizer, via its distributor, has provided registered medical portable ECG screening devices to Sunway Multicare...
August 08, 2023 | News
Proteintech, the benchmark in antibodies and life science solutions, recently expanded at its US headquarters in Rosemont, IL, opened up a new office in Sh...
August 07, 2023 | News
Certara, Inc. (Nasdaq: CERT), a global leader in Biosimulation, today announced that a Korea Institute of Toxicology (KIT) have decided to implement Certar...
August 04, 2023 | News
Currently, the Company's nanobathing products have been granted an invention patent and four utility model patents. Among them, one medical nanobathing car...
August 04, 2023 | News
To analyze individual cells, the desired number of cells must be isolated spatially. This often requires extensive training and use of expensive laboratory...
August 04, 2023 | News
The Phase I MAD study is a randomized, placebo-controlled, double-blind study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics ...
August 02, 2023 | News
The cOLE study offers an additional 9 months of treatment with Nefecon® to all qualifying patients who have completed the NefIgArd study and will evalu...
August 01, 2023 | News
Most Read
Bio Jobs
News